fasting-serum-c-peptide-test The relentless rise of antibiotic resistance necessitates the continuous discovery and development of new therapeutic agents. In this pursuit, peptide deformylase inhibitors have emerged as a particularly exciting class of compounds, offering a novel mechanism of action against a broad spectrum of bacterial pathogens.作者:SP East·2013·被引用次数:2—More than 30 years later the antibacterial activity of actinonin was attributed toinhibition of the metallohydrolase peptide deformylase(PDF), an enzyme that ... Peptide deformylase (PDF), an essential prokaryotic metalloenzyme, plays a crucial role in bacterial protein synthesis by catalyzing the hydrolytic removal of the N-terminal formyl group from nascent polypeptides.Synthesis and antimicrobial activities of novel peptide ... This critical function makes it an attractive target for the development of novel antibiotics.作者:M Arba·2020·被引用次数:3—Thepeptide deformylaseprotein (PDF) has emerged as a promising target for the discovery of novel antibiotics with a novel mechanism of ...
The significance of peptide deformylase lies in its essentiality for bacterial survival, while its absence in mammalian cells offers a degree of selectivity. This selectivity is paramount in drug development, as it minimizes potential off-target effects and toxicity in humans. Research has demonstrated that peptide deformylase inhibitors are selective for the bacterial enzyme, exhibiting minimal activity against similar mammalian enzymes, including those in humans.Peptide Deformylase Inhibitor - an overview This specificity is a cornerstone of their therapeutic potential.
The exploration of peptide deformylase inhibitors as antibacterial agents has a rich history.作者:X Hu·2004·被引用次数:79—Some of the macrocyclicinhibitorshad potent, broad spectrum antibacterial activity against clinically significant Gram-positive and Gram-negative pathogens. Early research identified natural products like Actinonin, a naturally occurring hydroxamic acid, as potent inhibitors of peptide deformylase.Peptide deformylase inhibitors refer tocompounds that inhibit the enzyme peptide deformylase, which is involved in bacterial protein synthesis. These early discoveries paved the way for further investigation into the structure-activity relationships of these compounds. The mechanism of action of these inhibitors involves disrupting the normal process of protein maturation, ultimately leading to either a bacteriostatic (inhibiting growth) or bactericidal (killing bacteria) effect, and potentially even indirect proinflammatory effects through the production of certain molecules.
More recent advancements have focused on rational design and structure-based approaches to discover and optimize peptide deformylase inhibitors作者:A Merzoug·2018·被引用次数:18—In this study, we report the structure-based virtual screening of ZINC database in order to discover potential hits as bacterialpeptidedeformylase enzyme .... Techniques like virtual screening of chemical databases have proven effective in identifying potential hits. For instance, studies have employed in silico techniques to discover PDF inhibitors specifically targeting enzymes like *P. aeruginosa* peptide deformylase (*PaPDF*)2025年9月18日—Peptide deformylase plays a crucial role in prokaryotic translationand constitutes an antibiotic target previously addressed in clinical trials .... The development of novel molecules, including macrocyclic inhibitors, has shown potent, broad-spectrum antibacterial activity against clinically significant Gram-positive and Gram-negative pathogens.作者:DRP Guay·2007·被引用次数:72—Peptide deformylase inhibitorsare selective for bacterial enzymeand exhibit activity against similar mammalian (including human) enzymes only ... These macrocyclic inhibitors often feature a hydroxamate moiety, similar to actinonin and matlystatin, which are established inhibitors of bacterial peptide deformylase.
The peptide deformylase enzyme is involved in prokaryotic translation, and its inhibition represents a novel mechanism of action compared to many existing antibiotics. This is particularly important in combating multidrug-resistant bacteria, where traditional therapeutic targets may no longer be effective. The pursuit of developing novel inhibitors continues, with ongoing research exploring diverse chemical scaffolds and strategies to enhance potency and overcome resistance mechanisms.
Furthermore, the potential applications of peptide deformylase inhibitors extend beyond general bacterial infectionsBacterial Peptide Deformylase Inhibitors: A New Class of .... Research has explored their efficacy as potent antimycobacterial agents, targeting bacteria responsible for diseases like tuberculosis.作者:A Merzoug·2018·被引用次数:18—In this study, we report the structure-based virtual screening of ZINC database in order to discover potential hits as bacterialpeptidedeformylase enzyme ... The ability of these inhibitors to selectively inhibit peptide deformylase for the treatment of diseases caused by bacterial infections underscores their therapeutic promise.
The journey of peptide deformylase inhibitors from initial discovery to potential clinical application involves rigorous scientific investigation. This includes understanding the enzyme's structure, identifying key binding sites, and synthesizing novel compounds with improved pharmacokinetic and pharmacodynamic properties.作者:MH Howard·2004·被引用次数:78—Peptide deformylase(PDF) has been identified as a promising antibacterial and herbicide target. A structurally novel class ofinhibitorscontaining a 2-thioxo- ... New inhibitors of peptide deformylase are continually being reported, with a focus on optimizing their efficacy and safety profiles作者:J Gao·2016·被引用次数:39—The recent research has confirmed thatpeptide deformylase(PDF) is a possible target to develop new antibacterial drugs [8,9]. PDF is an essential bacterial .... The field is dynamic, with ongoing efforts to discover novel peptide deformylase inhibitors and explore their cooperative interactions.
In summary, peptide deformylase inhibitors represent a significant and promising class of antibacterial agents.作者:SK Verma·2011·被引用次数:17—have two different effects for bacterial growth, a direct bacteriostatic or bactericidal effect and an indirect proinflammatory effect by the production of ... Their unique mechanism of action, targeting an essential bacterial enzyme with high selectivity, offers a critical advantage in the fight against infectious diseasesPeptide Deformylase Inhibitors. Continued research and development in this area hold the key to unlocking new therapeutic strategies and addressing the growing global challenge of antibiotic resistance. The exploration of peptide deformylase as an antibacterial drug target continues to yield exciting results, positioning these inhibitors as potentially one of the most impactful classes of antibacterial agents discovered to date.
Join the newsletter to receive news, updates, new products and freebies in your inbox.